A group of healthcare buyers from Sweden, Norway and Spain invites potentially interested bidders to participate in the open market consultation for their upcoming Carematrix pre-commercial procurement. The objective is to trigger testing and development of new solutions to anticipate and address the needs of people suffering from multimorbidity by ensuring timely service access, co-managed care journeys and transitions between specialities and sectors. The open market consultation is a combination of an RFI, questionnaire and webinars between November-December 2021.
CareMatrix is a European H2020 Pre-Commercial Procurement (PCP) project for integrated care solutions designed to challenge the health market to develop innovative technology for People with Multimorbidity (PMM).PMM are ageing populations with two or more chronic health conditions such as diabetes, heart disease and depression.
The projects' vision is to close the gap between supply and demand for innovative technology that enables predictive and specific care, treatment, administration and support needed for PMM. The project is to be developed in close dialogue between PMM, care providers and industry sectors based upon a solid demand-driven approach.
New solutions to anticipate and address the needs of people suffering from multimorbidity by ensuring timely service access, co-managed care journeys and transitions between specialities and sectors.
The CareMatrix project is now inviting any relevant organisation interested in being involved, including potential suppliers, MedTech experts, research organisations, patients' associations, care professionals' associations, and health care providers, to participate in the upcoming open market consultation.
Successful procurement requires involving technology companies and consortia at the earliest possible stage. The Open Market Consultation (OMC) aims at actively approaching the market to discover a state of art. The OMC consists of an in-depth dialogue and provides an overview of the procurement objectives, the PCP process and the main clauses of contracts. Information sharing will follow established procurement principles of fairness, transparency, and accessibility to information.
The CareMatrix OMC aims to:
- Initiate the formal dialogue between CareMatrix buyers and the market players
- Identify the gap between state-of-the-art industry development and the identified needs
- Provide a clear justification of the need to procure R&D services (confirm the PCP)
- Provide input to fine-tune the request for tender requirements (ITT) and its annexes
- Enable and increase the opportunities for the suppliers to form fit-for-purpose consortia
- Identify market risks potentially able to endanger business goals and supplier performance
The open market consultation takes place as a combination of an RFI, questionnaire and webinars between November-December 2021. For more information on the OMC stages, features and registration, visit https://carematrix.eu